McKesson's most recent trend suggests a bullish bias. One trading opportunity on McKesson is a Bull Put Spread using a strike $157.50 short put and a strike $152.50 long put offers a potential 19.05% return on risk over the next 28 calendar days. Maximum profit would be generated if the Bull Put Spread were to expire worthless, which would occur if the stock were above $157.50 by expiration. The full premium credit of $0.80 would be kept by the premium seller. The risk of $4.20 would be incurred if the stock dropped below the $152.50 long put strike price.
The 5-day moving average is moving up which suggests that the short-term momentum for McKesson is bullish and the probability of a rise in share price is higher if the stock starts trending.
The 20-day moving average is moving up which suggests that the medium-term momentum for McKesson is bullish.
The RSI indicator is at 73.87 level which suggests that the stock is neither overbought nor oversold at this time.
To learn how to execute such a strategy while accounting for risk and reward in the context of smart portfolio management, and see how to trade live with a successful professional trader, view more here
LATEST NEWS for McKesson
McKesson Corporation to Present at the 36th Annual J.P. Morgan Healthcare Conference
Tue, 19 Dec 2017 21:10:00 +0000
McKesson Corporation today announced that John Hammergren, chairman and chief executive officer, will present at the 36th Annual J.P. Morgan Healthcare Conference in San Francisco at 8:30 a.m.
Denver-based DEA opioid probe of McKesson was ‘hijacked,' says Washington Post-'60 Minutes' report
Tue, 19 Dec 2017 06:01:01 +0000
After years of investigation of McKesson Corp., led by a Denver-based Drug Enforcement Administration team, over the pharmaceutical giant's distribution of powerful opioid drugs in Colorado and elsewhere, DEA agents say they thought they had gathered enough evidence to warrant criminal charges and fines of more than $1 billion. The DEA probe examined whether San Francisco-based McKesson (MCK) failed to report suspicious orders of addictive opioid pain pills by pharmacies that in turn were supplying drug rings for illegal sale. “This is the best case we’ve ever had against a major distributor in the history of the [DEA],” David Schiller, who was assistant special agent in charge of the DEA’s Denver field division until his recent retirement, told the Washington Post.
Mckesson Corp (MCK) Chairman, President & CEO John H Hammergren Sold $10.4 million of Shares
Tue, 19 Dec 2017 03:15:01 +0000
Chairman, President & CEO of Mckesson Corp (NYSE:MCK) John H Hammergren sold 65,000 shares of MCK on 12/14/2017 at an average price of $160 a share.
Amplify Snack Brands and Akamai soar while McKesson slips
Mon, 18 Dec 2017 21:51:13 +0000
Stocks that moved substantially or traded heavily Monday: Amplify Snack Brands Inc., up $5.01 to $12.01 The Pop Secret maker agreed to be bought by Hershey for $1.2 billion. Snyder's-Lance Inc., up $3.25 …
Opioid Crisis: McKesson Corporation Stock Drops After 60 Minutes Report
Mon, 18 Dec 2017 18:02:00 +0000
The new 60 Minutes report on McKesson Corporation has to do with the current opioid crisis in the U.S. The report includes an interview with former members of the Drug Enforcement Administration (DEA). During the interview with the former DEA employees, they reveal that he organization was going to go after McKesson Corporation for its contribution to the opioid crisis.
Also on Market Tamer…
Follow Us on Facebook